Co-Diagnostics Says COVID-19 Diagnostics Suite Not Affected By Mutated Omicron Variant - Quick Facts
29/11 14:35
(RTTNews) - Molecular diagnostics company Co-Diagnostics, Inc. (CODX) reported Monday that none of the mutations in the heavily mutated SARS-CoV-2 variant recently discovered in Africa are predicted to interfere with any of the Company's suite of COVID-19 PCR diagnostic assays....